WHO ICTRP trial
A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the…
NL-OMON53427 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON53427 |
|---|---|
| Public title | A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL-23 Pathway to Establish Efficacy in Pediatric Crohn*s Disease;ISA title: A Phase 3, Multicenter, Randomized Clinical Study to Evaluate Mirikizumab in Pediatric Crohn*s Disease |
| Scientific title | A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL-23 Pathway to Establish Efficacy in Pediatric Crohn*s Disease;ISA title: A Phase 3, Multicenter, Randomized Clinical Study to Evaluate Mirikizumab in Pediatric Crohn*s Disease - Macaroni-23-Eli Lilly |
| Primary sponsor | Eli Lilly |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Phase | 3 |
| Countries | Australia;Austria;Belgium;Brazil;Canada;Czechia;France;Israel;Italy;Japan;Korea (the Democratic Peoples Republic of);Netherlands;Norway;Poland;Portugal;Spain;Switzerland;United Kingdom;United States… |
| Conditions | Chron's disease - granulomatous enteritis;10017969;Chron's disease - granulomatous enteritis |
| Interventions | ;Crohn's Disease;Efficacy;mirikizumab |
| Registration date | Sep 15, 2023 |
| Target size | 2 |
| Secondary IDs | 2022-000811-29;NL83188.056.22 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: